Nicotine

Overview

Nicotine used to arrive wrapped in smoke, and the smoke did most of the visible damage. Pouches and lozenges removed it. What is left is a fast, short-acting stimulant with no combustion products, no tar and no measurable cancer risk from the delivery route itself.

The gym and office world drew the obvious conclusion and got it wrong. Removing the smoke removed the part that caused cancer; it left the part that causes dependence entirely intact, and dependence is what nicotine is actually good at. This is not a mild stimulant with a bad historical association. It is the most reliably habit-forming compound in common legal use, now sold in a form with no smell, no ash and nothing to make anyone stop and count.

Mechanism of Action

Nicotine binds nicotinic acetylcholine receptors, primarily the α4β2 subtype in the brain, and mimics acetylcholine at them. Downstream, dopamine is released in the mesolimbic pathway, along with noradrenaline, acetylcholine and glutamate. The dopamine release is what makes it reinforcing; the noradrenaline is what makes it feel like alertness.

The receptors then do something that matters more than the acute effect. Under repeated exposure they desensitise and simultaneously upregulate in number. The system becomes both less responsive to nicotine and more dependent on having it present to function at its previous level.

A pouch delivers over roughly 20 to 40 minutes, slower and flatter than inhalation, which reaches the brain in seconds. That reduces the intensity of the hit without removing the reinforcement — it stretches it across the day instead, which is why pouch users typically take more separate doses than smokers took cigarettes. Plasma half-life is about two hours; cotinine, the main metabolite, persists around 16 hours and is what drug and pre-surgical testing looks for.

What It Actually Delivers

• Attention and reaction time: a real effect in people who have never used it, consistently small — the meta-analytic effect sizes sit in the range where an effect is detectable in a lab and hard to notice in a session
• Fine motor performance and working memory: measurably improved, again small
• Appetite: genuinely suppressed, through nicotinic receptors on the POMC neurons that regulate hunger — this is the largest and most dependable effect it has here
• Heart rate and blood pressure: raised with every dose
• Strength, endurance, hypertrophy: nothing. There is no ergogenic case for it

The honest summary is a small cognitive effect and a real appetite effect, attached to the fastest dependence curve on this site.

Why the Focus Stops Being a Gain

The first weeks are not the drug's normal state, and nearly everyone judges it by them.

Once receptors have upregulated, baseline function without nicotine sits lower than it did before the first pouch. A dose returns it to roughly where it started. From the inside this is indistinguishable from an improvement — concentration genuinely does sharpen, the fog genuinely does lift — because the comparison being made is against withdrawal, not against the person who was never using it.

Caffeine does the same thing, which is why the caffeine page says the same about a 400 mg baseline. The difference is speed and depth. Caffeine tolerance takes weeks and the withdrawal is a few days of headaches. Nicotine can establish loss of control within weeks of use that is not yet daily, and it holds. Someone taking a pouch to focus on a Tuesday afternoon has usually stopped choosing it by then. The practical test is unglamorous: skip a day, and whatever remains of the effect afterwards is the real one.

Vasoconstriction, Tendon Healing and Surgery

This is where nicotine stops being an abstract habit problem for this readership.

Nicotine constricts peripheral blood vessels and reduces perfusion in exactly the tissues that heal slowly to begin with. Tendon, ligament, bone and skin all depend on blood supply that is marginal under the best conditions. The clinical record in smokers is unambiguous — higher rates of fracture non-union, failed spinal fusion, rotator cuff repair failure, wound breakdown and flap necrosis. Orthopaedic and plastic surgeons treat continued nicotine use as a reason to postpone elective procedures, and cotinine testing is routine before some of them.

The caveat has to be stated: most of that human data comes from smoking, which delivers carbon monoxide and thousands of other compounds alongside the nicotine. Isolated nicotine has been shown to impair tendon-to-bone healing and collagen deposition in animal models, and the vasoconstriction itself is directly measurable in humans. The mechanism is not in doubt; the size of nicotine's independent share of the clinical effect is.

For anyone rehabbing a tendinopathy, waiting on a repair, or in the months after surgery, that uncertainty runs the wrong way. A pouch will not show up as slower healing. It will show up as a rehab that takes longer than it should for no apparent reason.

The Diet Case, and What It Costs

Appetite suppression is the reason nicotine gets used seriously in this space, and it works. Smokers weigh several kilograms less than non-smokers on average, and the effect has an identified mechanism rather than being an artefact of who smokes.

Used in a deficit, that is a real advantage — hunger is what ends most diets. But this is also the dosing pattern with the highest frequency: not one pouch before training, but a pouch whenever hunger arrives, all day, for the length of the prep.

The diet has an end date. The receptor upregulation does not follow it. Coming off produces one to three weeks of irritability, poor concentration and disrupted sleep, with appetite rebounding above where it started — the documented average weight gain after nicotine cessation is four to five kilograms. The suppression was borrowed, and the loan comes due after the show.

Side Effects & Risks

• Dependence, rapidly established and persistent
• Raised heart rate and blood pressure with every dose, additive with caffeine, ephedrine, clenbuterol and yohimbine
• Peripheral vasoconstriction, with impaired wound, bone and tendon healing
• Gum recession, oral mucosal lesions and local irritation at the pouch site — recession is permanent
• Fragmented sleep from overnight withdrawal, often unrecognised as such
• Nausea, vomiting, dizziness and sweating in non-tolerant users, particularly with high-strength pouches
• Reduced insulin sensitivity and modestly raised fasting glucose
• Ongoing cardiovascular risk from sustained sympathetic activation; lower than smoking, not zero
• Contraindicated in pregnancy, a documented risk to the developing brain under roughly 25, and not safe alongside arrhythmia, uncontrolled hypertension or existing cardiac disease

Blood Work & Monitoring

• Blood pressure and resting heart rate — measured with a cuff, not estimated, and counted alongside a cycle rather than treated as separate
• Fasting glucose and HbA1c — if use is heavy and prolonged, or alongside growth hormone or insulin
• Cotinine — not a health marker but the test surgeons use; a positive result before an elective orthopaedic procedure can postpone it, and pouches trigger it exactly as cigarettes do
• Haematocrit — the elevation seen in smokers comes from carbon monoxide, not nicotine, so a pouch does not add to it; on a cycle where haematocrit is already climbing, that distinction is worth knowing rather than assuming
• No routine lab monitoring is otherwise indicated. The meaningful measurement is behavioural: whether a day without it is uneventful